Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
Status: Enrolling
Updated:  3/21/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
Status: Enrolling
Updated: 3/21/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
Status: Enrolling
Updated:  3/21/2018
Texas Children's Hospital
mi
from
Houston, TX
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
Status: Enrolling
Updated: 3/21/2018
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
Status: Enrolling
Updated:  3/21/2018
Boston Children's Hospital
mi
from
Boston, MA
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
Status: Enrolling
Updated: 3/21/2018
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)
Contrast- Enhanced Whole-Heart Coronary Magnetic Resonance Angiography (MRA) at 3.0T
Status: Enrolling
Updated:  3/21/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)
Contrast- Enhanced Whole-Heart Coronary Magnetic Resonance Angiography (MRA) at 3.0T
Status: Enrolling
Updated: 3/21/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Scripps Green Hospital
mi
from
La Jolla, CA
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Scripps Green Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Stanford Hospital and Clinics
mi
from
Palo Alto, CA
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Stanford Hospital and Clinics
mi
from
Palo Alto, CA
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Mercy General Hospital
mi
from
Sacramento, CA
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Mercy General Hospital
mi
from
Sacramento, CA
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
University of Colorado Hospital
mi
from
Denver, CO
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
University of Colorado Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Morton Plant Hospital
mi
from
Clearwater, FL
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Morton Plant Hospital
mi
from
Clearwater, FL
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
University of Florida
mi
from
Gainesville, FL
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Emory University
mi
from
Atlanta, GA
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Northwestern University
mi
from
Chicago, IL
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Rush University Medical Center
mi
from
Chicago, IL
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Northshore University Healthsystem Research Institute
mi
from
Evanston, IL
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Northshore University Healthsystem Research Institute
mi
from
Evanston, IL
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Prairie Education and Research Cooperative
mi
from
Springfield, IL
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Prairie Education and Research Cooperative
mi
from
Springfield, IL
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Indiana University Health Methodist Hospital
mi
from
Indianapolis, IN
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Indiana University Health Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
St. Vincent Medical Group, Inc./St. Vincent Heart Center of Indiana, LLC
mi
from
Indianapolis, IN
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
St. Vincent Medical Group, Inc./St. Vincent Heart Center of Indiana, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
University of Louisville - Jewish Hospital
mi
from
Louisville, KY
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
University of Louisville - Jewish Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Ochsner Clinic Foundation
mi
from
New Orleans, LA
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
MedStar Union Memorial Hospital
mi
from
Baltimore, MD
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
MedStar Union Memorial Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
University of Maryland Medical Center
mi
from
Baltimore, MD
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Massachusetts General Hospital
mi
from
Boston, MA
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Brigham and Women's Hosp
mi
from
Boston, MA
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
University of Michigan Hospital and Health Systems
mi
from
Ann Arbor, MI
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
University of Michigan Hospital and Health Systems
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Henry Ford Hospital
mi
from
Detroit, MI
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
William Beaumont Hospital
mi
from
Royal Oak, MI
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Minneapolis Heart Institute Foundation
mi
from
Minneapolis, MN
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Minneapolis Heart Institute Foundation
mi
from
Minneapolis, MN
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Mayo Clinic - Saint Marys Hospital
mi
from
Rochester, MN
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Mayo Clinic - Saint Marys Hospital
mi
from
Rochester, MN
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Saint Luke's Hospital of Kansas City Mid America
mi
from
Kansas City, MO
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Saint Luke's Hospital of Kansas City Mid America
mi
from
Kansas City, MO
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Washington University/ Barnes-Jewish Hospital
mi
from
Saint Louis, MO
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Washington University/ Barnes-Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Nebraska Heart Institute
mi
from
Lincoln, NE
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Nebraska Heart Institute
mi
from
Lincoln, NE
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Newark Beth Israel Medical Center
mi
from
Newark, NJ
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Winthrop University Hospital
mi
from
Mineola, NY
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Cornell University
mi
from
New York, NY
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Columbia University Medical Center
mi
from
New York, NY
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Northshore Long Island Jewish Health System
mi
from
New York, NY
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Northshore Long Island Jewish Health System
mi
from
New York, NY
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Medical University of South Carolina Charleston
mi
from
Charleston, NC
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Medical University of South Carolina Charleston
mi
from
Charleston, NC
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Duke Univ Med Ctr
mi
from
Durham, NC
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
The Christ Hospital
mi
from
Cincinnati, OH
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
The Christ Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Oklahoma Cardiovascular Research Group
mi
from
Oklahoma City, OK
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Oklahoma Cardiovascular Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Providence Heart & Vascular Institute
mi
from
Portland, OR
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Providence Heart & Vascular Institute
mi
from
Portland, OR
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Baptist Memorial Hospital
mi
from
Memphis, TN
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Baptist Memorial Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Austin Heart, P.A.
mi
from
Austin, TX
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Austin Heart, P.A.
mi
from
Austin, TX
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
Medical City Dallas Hospital
mi
from
Dallas, TX
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
Medical City Dallas Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
University of Texas Health Science Center at Houston
mi
from
Houston, TX
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated:  3/21/2018
The Heart Hospital Baylor Plano
mi
from
Plano, TX
The PARTNER II Trial: S3iCAP
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Status: Enrolling
Updated: 3/21/2018
The Heart Hospital Baylor Plano
mi
from
Plano, TX
Click here to add this to my saved trials